JPMorgan Chase Acquires M-Modal in $1.1 Billion Deal

Thanh Le | | Radiology Business | Business Intelligence
M-Modal (NASDAQ/GS: MODL), a provider of clinical documentation services and cloud-based voice recognition software, and One Equity Partners, the private investment arm of JPMorgan Chase, announced an agreement where One Equity Partners will acquire all outstanding shares of M-Modal for $14.00 per share in an all-cash transaction that is valued at approximately $1.1 billion. Under the terms of the agreement, which was unanimously approved by M-Modal’s Board of Directors, M-Modal shareholders will receive $14 in cash for each outstanding share of M-Modal common stock they own representing an 8.3% premium over the closing price on July 2, 2012, the last full trading day before the announcement. The deal is expected to close during the third quarter of 2012. It is anticipated that affiliates of One Equity Partners will commence a tender offer for all shares of M-Modal no later than July 17. The M-Modal board has unanimously recommended that all shareholders accept the offer. “M-Modal presents a unique opportunity to acquire a market leader in clinical documentation at a time when the company has successfully released its new generation of speech understanding solutions for healthcare,” said Dick Cashin, Managing Partner of One Equity Partners, in the press release.

Thanh Le

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.